Ototoxic drugs: difference in sensitivity between mice and guinea pigs
- PMID: 20015469
- DOI: 10.1016/j.toxlet.2009.12.003
Ototoxic drugs: difference in sensitivity between mice and guinea pigs
Abstract
The development of experimental animal models has played an invaluable role in understanding the mechanisms of neurosensory deafness and in devising effective treatments. The purpose of this study was to develop an adult mouse model of ototoxic drug-induced hearing loss and to compare the ototoxicity in the adult mouse to that in the well-described guinea pig model. Mice are a powerful model organism, especially due to the large availability of antibodies, probes and genetic mutants. In this study, mice (n=114) and guinea pigs (n=35) underwent systemic treatment with either kanamycin or cisplatin. Auditory brainstem responses showed a significant threshold shift in guinea pigs 2 weeks after the beginning of the ototoxic treatment, while there was no significant hearing impairment recorded in mice. Hair cells and neuronal loss were correlated with hearing function in both guinea pigs and mice. These results indicate that the mouse is not a good model for ototoxicity, which should be taken into consideration in all further investigations concerning ototoxicity-induced hearing loss.
Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
[Reduced nutritional status enhances ototoxicity].Laryngorhinootologie. 1995 Dec;74(12):724-7. doi: 10.1055/s-2007-997833. Laryngorhinootologie. 1995. PMID: 8579670 German.
-
[Aminoglycoside- and cisplatin-ototoxicity: from basic science to clinics].Laryngorhinootologie. 2004 May;83(5):317-23. doi: 10.1055/s-2004-814280. Laryngorhinootologie. 2004. PMID: 15143449 Review. German.
-
End points for cisplatin ototoxicity.J Otolaryngol Head Neck Surg. 2011 Feb;40 Suppl 1:S45-8. J Otolaryngol Head Neck Surg. 2011. PMID: 21453661
-
Recovery of hearing following cisplatin ototoxicity in the guinea pig.Anticancer Res. 2002 May-Jun;22(3):1525-8. Anticancer Res. 2002. PMID: 12168832
-
[Ototoxicity of drugs].Clin Ter. 1986 Jul 31;118(2):137-43. Clin Ter. 1986. PMID: 2874911 Review. Italian. No abstract available.
Cited by
-
Induced Pluripotent Stem Cells, a Stepping Stone to In Vitro Human Models of Hearing Loss.Cells. 2022 Oct 21;11(20):3331. doi: 10.3390/cells11203331. Cells. 2022. PMID: 36291196 Free PMC article. Review.
-
Examination of calcium-binding protein expression in the inner ear of wild-type, heterozygous and homozygous pituitary adenylate cyclase-activating polypeptide (PACAP)-knockout mice in kanamycin-induced ototoxicity.Neurotox Res. 2014 Jan;25(1):57-67. doi: 10.1007/s12640-013-9428-x. Epub 2013 Oct 24. Neurotox Res. 2014. PMID: 24155155
-
An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity.Hear Res. 2019 Apr;375:66-74. doi: 10.1016/j.heares.2019.02.006. Epub 2019 Feb 22. Hear Res. 2019. PMID: 30827780 Free PMC article.
-
GLAST Deficiency in Mice Exacerbates Gap Detection Deficits in a Model of Salicylate-Induced Tinnitus.Front Behav Neurosci. 2016 Aug 17;10:158. doi: 10.3389/fnbeh.2016.00158. eCollection 2016. Front Behav Neurosci. 2016. PMID: 27582696 Free PMC article.
-
Necroptosis and Apoptosis Contribute to Cisplatin and Aminoglycoside Ototoxicity.J Neurosci. 2019 Apr 10;39(15):2951-2964. doi: 10.1523/JNEUROSCI.1384-18.2019. Epub 2019 Feb 7. J Neurosci. 2019. PMID: 30733218 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical